U.S. cancer death rate hits 25th year of decline
Lower smoking rates are translating into fewer deaths. Advances in early detection and treatment also are having a positive impact, experts say.
Diseases
Articles
Two IU researchers win $2.3M grant to study neuropathy in cancer patients
The researchers are testing the effectiveness of a small, targeted molecule to prevent or reverse chemotherapy-induced peripheral neuropathy—a nerve problem that causes pain, numbness and tingling.
Eli Lilly partner urges investors to look beyond biotech turmoil
Look at the future prospects, not the losses, says the CEO of a newly listed Chinese biotech company that’s developing anti-cancer drugs with Indianapolis-based Eli Lilly and Co.
Endocyte’s $2.1B deal with Novartis comes after years of setbacks
The West Lafayette biotech firm’s stock traded as low as $1.41 last fall, following multiple setbacks and restructurings. But the stock had soared to $24 Thursday morning after news that it would be acquired by Novartis.
Hunger, food insecurity continue to vex Indiana residents
In Indiana, one million people face food insecurity, and in Indianapolis the number is approaching nearly 175,000—or more than 18 percent of the population.
IU researcher wins $44.7M to study rare form of Alzheimer’s disease
The IU School of Medicine said the grant, its largest-ever National Institutes of Health award, will fund a five-year study of a form of Alzheimer’s disease that affects young people.
Lilly might market diabetes drug for obesity after research results
Eli Lilly and Co.’s stock jumped Thursday after midstage research on an experimental diabetes drug showed significant weight loss in patients. The news took a toll on shares of rival Novo Nordisk.
Roche using data-driven diagnostic tools to reshape patient care
The company, which employs more than 3,000 on the northeast side, has been struggling on the diabetes side of its business. To bounce back, it is investing heavily in diagnostics, and is working to commercialize several products it hopes will be game-changers.
U.S. flu season worst in four decades, claims 80,000 lives
The tally of fatalities was nearly twice as large as what health officials previously considered a bad year, the director of Centers for Disease Control and Prevention said.
New report moves Indiana out of top 10 fattest states
Of course, Indiana’s improved ranking doesn’t necessarily mean Hoosiers are slimming down, and could simply reflect that other states are getting worse.
Health officials urge diners at downtown restaurant to get checked for hepatitis
A food worker at the restaurant tested positive for the virus and might have infected customers on Aug. 6, according to the Marion County Public Health Department.
IU School of Medicine to spend $20M to launch regenerative medicine center
The center aims to develop new treatments for diabetes, severe wounds, and damage to tissues and organs caused by age, disease or trauma.
Q&A: What’s behind the growing scrutiny of insulin prices?
The American Medical Association recently called on regulators to monitor competition among the three drugmakers who control the market—Indianapolis-based Eli Lilly and Co., Denmark-based Novo Nordisk and Paris-based Sanofi.
China cuts red tape, increases potential for breakthrough medicines
After decades of being starved of innovative treatments for serious conditions like cancer, diabetes and kidney disease, China’s 1.4 billion people are becoming a prime target for Eli Lilly and other pharmaceutical companies.
IU aims to find cures for three forms of cancer, help prevent or slow other diseases
The university said it has hired 33 research faculty to help under the “Grand Challenges” program in precision health, an initiative it rolled out two years ago.
Trial of potential Alzheimer’s treatment shows rare positive results
While the ultimate outcome remains far from certain, the study is a bright spot—if a tenuous one—in the search for a treatment for Alzheimer’s, where more than 100 experimental drugs have failed.
In setback for Lilly, FDA limits dosage, slaps warning on new arthritis drug
The Indianapolis-based drugmaker has been working for years to develop the much-anticipated drug, which some analysts had said might ring up $2 billion a year in sales.
Gene therapies that could transform diseases get easier FDA path
New therapies that could cure diseases caused by defective genes will get quicker approval from U.S. regulators, part of an effort by the Food and Drug Administration to keep pace with one of biotechnology’s fastest-growing fields.
Marion County declares hepatitis C epidemic, proposes syringe exchange
City-County Council will consider May 21 whether to launch a syringe exchange program here in an effort to cut down the growing number of hepatitis C cases, which officials are linking to the opioid epidemic.
Crawfordsville startup CorVus fattens pigs for science
The newly built farm uses a high-fat, high-cholesterol diet to give animals heart disease and diabetes to help medical researchers find treatments.